AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CYCLOSPORINE
7 registrations across 3 African markets— 6 active
Markets with CYCLOSPORINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| PANIMUN BIORAL 25MG CAPSULE; ORAL | 🇿🇼Zimbabwe | PANACEA BIOTEC PHARMA LIMITED | active | May 2030 |
| PANIMUN BIORAL 100 MG CAPSULE; ORAL | 🇿🇼Zimbabwe | PANACEA BIOTEC PHARMA LIMITED | active | Dec 2027 |
| CYCLOSPORINE 25MG SOFT GELATIN CAPSULES | 🇬🇭Ghana | — | active | Sept 2026 |
| CYCLOSPORINE 25MG SOFT GELATIN CAPSULES | 🇬🇭Ghana | — | expired | Sept 2026 |
| CYCLOSPORINE 25MG SOFT GELATIN CAPSULES | 🇬🇭Ghana | — | active | Sept 2026 |
| Panimun Bioral 25 mg Capsules, soft | 🇹🇿Tanzania | PANACEA BIOTEC PHARMA LIMITED | active | — |
| Panimun Bioral 100 mg Capsules | 🇹🇿Tanzania | PANACEA BIOTEC PHARMA LIMITED | active | — |
CYCLOSPORINE in Africa — Regulatory Overview
CYCLOSPORINE is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Tanzania, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 6 (86%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.